Suppr超能文献

一个为ST段抬高型心肌梗死患者及时提供经皮冠状动脉介入治疗的区域系统。

A regional system to provide timely access to percutaneous coronary intervention for ST-elevation myocardial infarction.

作者信息

Henry Timothy D, Sharkey Scott W, Burke M Nicholas, Chavez Ivan J, Graham Kevin J, Henry Christopher R, Lips Daniel L, Madison James D, Menssen Katie M, Mooney Michael R, Newell Marc C, Pedersen Wes R, Poulose Anil K, Traverse Jay H, Unger Barbara T, Wang Yale L, Larson David M

机构信息

Minneapolis Heart Institute Foundation, 920 E 28th St, Ste 40, Minneapolis, MN 55407, USA.

出版信息

Circulation. 2007 Aug 14;116(7):721-8. doi: 10.1161/CIRCULATIONAHA.107.694141. Epub 2007 Aug 1.

Abstract

BACKGROUND

Percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) is superior to fibrinolysis when performed in a timely manner in high-volume centers. Recent European trials suggest that transfer for PCI also may be superior to fibrinolysis and increase access to PCI. In the United States, transfer times are consistently long; therefore, many believe a transfer for PCI strategy for STEMI is not practical.

METHODS AND RESULTS

We developed a standardized PCI-based treatment system for STEMI patients from 30 hospitals up to 210 miles from a PCI center. From March 2003 to November 2006, 1345 consecutive STEMI patients were treated, including 1048 patients transferred from non-PCI hospitals. The median first door-to-balloon time for patients <60 miles (zone 1) and 60 to 210 miles (zone 2) from the PCI center was 95 minutes (25th and 75th percentiles, 82 and 116 minutes) and 120 minutes (25th and 75th percentiles, 100 and 145 minutes), respectively. Despite the high-risk unselected patient population (cardiogenic shock, 12.3%; cardiac arrest, 10.8%; and elderly [> or =80 years of age], 14.6%), in-hospital mortality was 4.2%, and median length of stay was 3 days.

CONCLUSIONS

Rapid transfer of STEMI patients from community hospitals up to 210 miles from a PCI center is safe and feasible using a standardized protocol with an integrated transfer system.

摘要

背景

在高容量中心及时进行经皮冠状动脉介入治疗(PCI)治疗ST段抬高型心肌梗死(STEMI)优于纤溶治疗。近期欧洲的试验表明,转至行PCI治疗也可能优于纤溶治疗,并增加了接受PCI治疗的机会。在美国,转院时间一直很长;因此,许多人认为针对STEMI的转至行PCI治疗策略不实用。

方法与结果

我们为距离PCI中心达210英里的30家医院的STEMI患者开发了一种基于PCI的标准化治疗系统。从2003年3月至2006年11月,连续治疗了1345例STEMI患者,其中包括1048例从非PCI医院转来的患者。距离PCI中心<60英里(1区)和60至210英里(2区)的患者首次门球时间中位数分别为95分钟(第25和第75百分位数,82和116分钟)和120分钟(第25和第75百分位数,100和145分钟)。尽管患者群体未经过选择且风险高(心源性休克占12.3%;心脏骤停占10.8%;老年人[≥80岁]占14.6%),但住院死亡率为4.2%,中位住院时间为3天。

结论

使用标准化方案和综合转运系统,将距离PCI中心达210英里的社区医院的STEMI患者快速转运是安全可行的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验